Conference Call to Discuss Third Quarter Fiscal 2021 Results MISSISSAUGA, ON, Aug. 26, 2021 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2021 financial results on Monday, August 30, 2021 before markets open. A conference call to discuss the financial results will be held on Monday, August 30, 2021 at 9:00am EST. To participate in the conference call, please dial:
North American Toll-Free: 1.888.664.6392
Local (Toronto): 416.764.8659
Confirmation Number: 01860859
A recording of the call will be available by calling 1.888.390.0541 or 416.764.8677 and entering the encore replay entry code 860859# until September 13, 2021. A recording of the call will also be available on www.covalon.com under News & Events on the Investors tab.
Copies of Covalon's financial statements and MD&A can be obtained on SEDAR at www.sedar.com and under Sedar Filings on the Investors tab of Covalon's website.
About Covalon
Covalon Technologies Ltd. is a researcher, developer, manufacturer, and marketer of patent-protected medical products that improve patient outcomes and save lives in the areas of advanced wound care, infection management and surgical procedures. Covalon leverages its patented medical technology platforms and expertise in two ways: (i) by developing products that are sold under Covalon's name; and (ii) by developing and commercializing medical products for other medical companies under development and license contracts. The Company is listed on the TSX Venture Exchange, having the symbol COV and trades on the OTQX Market under the symbol CVALF. To learn more about Covalon, visit our website at www.covalon.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.